Trial Profile
A Trial to Determine the Effect of Psoriasis Treatment on Cardiometabolic Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Plaque psoriasis
- Focus Biomarker; Pharmacodynamics
- Acronyms VIP
- 01 Jun 2019 Results assessing patient reported outcomes of adalimumab in published in patients with psoriasis, the Journal of the American Academy of Dermatology.
- 23 Apr 2018 Status changed from active, no longer recruiting to completed.
- 11 Jun 2015 Status changed from not yet recruiting to active,no longer recruiting as reported by ClinicalTrials.gov.